NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Obalon Therapeutics, Inc. (NASDAQGM: OBLN) concerning possible violations of federal securities laws. On January 23, 2018, Obalon announced the termination of an underwriting agreement and cancellation of its previously-announced public offering. To obtain additional information, go to :
http://www.zlkdocs.com/OBLN-Info-Request-Form-6401
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you .
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firmâ€™s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders . For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com : http://www.businesswire.com/news/home/20180123006491/en/
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
Source: Levi & Korsinsky, LLP